Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO
Reuters
Fri, 01/5/24 - 11:28 am
Tags:
Merck
,
Pharma CEOs
,
Rob Davis
,
GLP-1 agonist
Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report
Fierce Pharma
Fri, 01/5/24 - 10:08 am
Tags:
Merck
,
legal
,
cybersecurity
,
cyberattacks
FDA ends busy year with three drug rejections
BioPharma Dive
Tue, 01/2/24 - 10:13 pm
Tags:
FDA
,
Amgen
,
Zealand Pharma
,
Merck
Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time
BioSpace
Thu, 12/21/23 - 11:36 am
Tags:
Merck
,
gefapixant
,
chronic cough
,
FDA
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
Pharmaceutical Technology
Wed, 12/20/23 - 09:34 am
Tags:
Merck
,
vaccines
,
FDA
,
pneumococcal disease
,
V116
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Tags:
Merck
,
Astellas
,
Pfizer
,
Keytruda
,
Padcev
,
bladder cancer
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Tags:
Moderna Therapeutics
,
Merck
,
vaccines
,
Keytruda
,
melanoma
,
MRNA
Merck offers up to $610M for one of C4’s protein degraders
Fierce Biotech
Tue, 12/12/23 - 11:07 am
Tags:
Merck
,
C4 Therapeutics
,
protein degradation
Moderna, Merck begin late-stage study for mRNA cancer therapy
Reuters
Mon, 12/11/23 - 10:00 am
Tags:
Moderna Therapeutics
,
Merck
,
MRNA
,
cancer
,
clinical trials
Merck suffers bad week as 3 Keytruda combination trials fail
BioPharma Dive
Sun, 12/10/23 - 11:19 pm
Tags:
Merck
,
Keytruda
,
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Tags:
Merck
,
Eisai
,
4523.T
,
clinical trials
,
endometrial cancer
,
Keytruda
,
Lenvima
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer
Fierce Pharma
Thu, 12/7/23 - 12:00 pm
Tags:
Merck
,
Keytruda
,
non-small cell lung cancer
,
Lynparza
,
AstraZeneca
Merck partners with HiberCell for Phase Ib renal carcinoma trial
Clinical Trials Arena
Wed, 12/6/23 - 10:29 am
Tags:
Merck
,
HiberCell
,
Welireg
,
HC-7366
,
renal cell carcinoma
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Tags:
Bristol Myers Squibb
,
Opdivo
,
bladder cancer
,
urothelial cancer
,
Merck
,
Seagen
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Tags:
Merck
,
Astellas
,
Seagen
,
Padcev
,
bladder cancer
,
FDA
,
priority review
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Tags:
Merck
,
GSK
,
chronic cough
,
Bellus Health
,
gefapixant
,
Camlipixant
Merck turns to Acclinate to increase African American participation in cancer trials
Fierce Biotech
Thu, 11/30/23 - 09:52 am
Tags:
Merck
,
clinical trials
,
clinical trial diversity
,
Acclinate
,
cancer
,
digital health
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Tue, 11/28/23 - 11:52 am
Tags:
Merck
,
Pfizer
,
vaccines
,
clinical trials
,
pneumococcal disease
,
V116
,
Prevnar 20
Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics
BioSpace
Tue, 11/21/23 - 12:05 pm
Tags:
Merck
,
M&A
,
neurodegenerative disease
,
Caraway Therapeutics
5 Cancer Vaccines to Watch in 2024
BioSpace
Mon, 11/20/23 - 10:15 am
Tags:
Merck
,
Moderna Therapeutics
,
melanoma
,
BioNTech
,
pancreatic cancer
,
OSE Immunotherapeutics
,
Transgene
,
non-small cell lung cancer
,
Nykode Therapeutics
,
cervical cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.